PROBLEM TO BE SOLVED: To provide a combination and a method of a therapeutic agent for treating cancer by using a combination therapy. It can activate (i) effective amounts of targeted therapeutics and (ii) human plasmacytoid dendritic cells, myeloid dendritic cells, or NK cells, or a combination thereof. A combination comprising an effective amount of an immunotherapeutic agent. [Selection diagram] FIG. 1A